Drawing for AVANTUM

USPTO serial 86883863

AVANTUM

Reviewed by CopyMark Law Group

Reg. 5740077Status 702Registered
Filing date
Status date
Registration date
Apr 30, 2019
Examiner
MAI, TINA HSIN
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with AVANTUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Peter Nussbaum

Peter Nussbaum Chiesa Shahinian & Giantomasi Pc105 Eisenhower ParkwayRoseland, NJ 07068United States

Goods and services

ClassDescriptionStatusFirst use
044Institutional pharmacy services, namely, pharmaceutical advice and dispensing pharmaceutical products, prescription drugs, and medications to healthcare facilities; Pharmaceutical consultation; Dispensing of pharmaceuticals; Preparation and dispensing of medications; Providing information to patients in the field of administering medications; Maintaining patient medical records for assisted living and long term care facilities and physicians; Providing healthcare and pharmaceutical advice to assisted living and long-term care facilities, their residents, patients, and physicians; Providing a web-based system and online portal in the field of pharmacy services for long term care facilities and providers, skilled nursing facilities, assisted living communities, doctors and medical providers and their staff, patients and residents to communicate with each other and with pharmacy providers regarding information relating to pharmaceutical dosage information and administration of medication; Providing a web-based system and online portal that allows long term care facilities and providers, skilled nursing facilities, assisted living communities, doctors and medical providers and their staff, patients and residents to access medical testing reports, medicine regimen review and patient medical records to assist in providing health information and for the purpose of monitoring and treating medical conditions and administering medications; Leasing of durable medical equipment; Health care services, namely, urological, ostomy and skin care and rehabilitation services for nursing home patients, namely, physical therapy, occupational therapy and speech therapy; Pharmaceutical consulting services provided to entities that care for senior citizens in the field of medication therapy managementACTIVEDec 31, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 12, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Dec 12, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Dec 12, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 9, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Apr 30, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 26, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 26, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 26, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 30, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 26, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 25, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 15, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 14, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 25, 2019IUAFUSE AMENDMENT FILED—
Feb 25, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 14, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 10, 2018EX4GSOU EXTENSION 4 GRANTED—
Aug 10, 2018EXT4SOU EXTENSION 4 FILED—
Aug 10, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 12, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 8, 2017EX3GSOU EXTENSION 3 GRANTED—
Dec 8, 2017EXT3SOU EXTENSION 3 FILED—
Dec 8, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 8, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 6, 2017EX2GSOU EXTENSION 2 GRANTED—
Aug 6, 2017EXT2SOU EXTENSION 2 FILED—
Aug 6, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 24, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 21, 2017EX1GSOU EXTENSION 1 GRANTED—
Jan 21, 2017EXT1SOU EXTENSION 1 FILED—
Jan 21, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 21, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 23, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 28, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 28, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 8, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 16, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 16, 2016XAECEXAMINER'S AMENDMENT ENTERED—
May 16, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 16, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
May 16, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
May 11, 2016ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 11, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 7, 2016DOCKASSIGNED TO EXAMINER—
Jan 28, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 26, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance